The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), expanding the product’s indications to include ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

coli outbreak linked to raw onions served on McDonald's Quarter Pounders weeks ago has climbed, but there no longer appears to be any food safety concerns at the fast food giant's restaurants, ...

Opioid overdose deaths have decreased for 12 months, with 70,655 predicted deaths through June 2024, down from 86,401 in June ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

HUNTINGTON, W.Va. (WSAZ) - The U.S. Food and Drug Administration has authorized the first over-the-counter test that can ...

Bluebird bio Inc., which nine years ago was worth nearly as much as the airline JetBlue, said it's now looking for enough ...

Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered ...

Part 3 of this series for Global Biosimilars Week, penned by Dracey Poore, director of biosimilars at Cardinal Health, ...

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...

Clinical development and trial testing of vesleteplirsen (SRP-5051) for Duchenne muscular dystrophy (DMD) was stopped, with ...